Sentences with phrase «biopharmaceutical company regeneron»
The biopharmaceutical company, formerly known as GeNO LLC, designs, develops and commercializes products for patients with pulmonary and cardiac diseases.
http://rebusinessonline.com/
Medical Screener KEDPlasma LLC Burlington, NC Kedrion is a biopharmaceutical company specializing in the development, production and distribution of plasma...
A Research Scientist / Scientist / Principal Scientist position in a biopharmaceutical company
SUMMARY Self - Motivated, accomplished, enthusiastic and focused Professional Healthcare Representative with over 20 years of outstanding sales success with the largest Biopharmaceutical Company in the industry.
Summary of Qualifications * President and owner Coastal Drug Institutional Pharmacy in Maryland * 10 yrs as Pharmacist in Charge for Long Term Care Pharmacy * Senior Management Consultant for Big 5 consulting firm * Six Sigma Black Belt * Associate Director of Project Management for biopharmaceutical company * Director of Clinical Benchmarking for mid-tier consulting firm * Project Manager for top 10 pharmaceutical company *...
A global biopharmaceutical company dedicated to discovering, developing and bringing to market medications with total revenue of $ 2.81 billion in 2010 (with approx 4,000 employees).
Kelly Scientific is seeking candidates for a document control project in a biopharmaceutical company in...
We are seeking a Licensed Vocational Nurse (LVN) to join our growing biopharmaceutical company.
For Leslie Dunlop, vice president and corporate counsel at Bioniche Life Sciences Inc., a publicly traded, Belleville, Ont. - based biopharmaceutical company that «discovers, develops, manufactures, and markets proprietary products for human and animal health markets,» a constant issue for her and her company is adhering to the many regulatory requirements of securities law, including the obligation to disclose material information in a timely way.
A biopharmaceutical company is just getting started with vendor management according to the legal operations manager.
Shire's CSO leads tech transformation programme FTSE 100 biopharmaceutical company Shire, led by chief strategy officer Claire Debney and legal strategy manager Ama Zbarcea, has conducted an extensive sandbox exercise to engage its staff in the selection of a contract management system, as part of a much wider technology - led transformation programme.
Kiadis Pharma is a clinical stage biopharmaceutical company developing innovative products to make bone marrow transplantations safer.
FTSE 100 biopharmaceutical company Shire, led by director of legal strategy Claire Debney (pictured top left) and legal strategy manager Ama Zbarcea, has conducted an extensive sandbox exercise to engage its staff in the selection of a contract management system, as part of a much wider technologyled transformation programme.
Don also served as Director, Legal for Cytogen Corporation (NASDAQ: CYTO), a publicly - traded biopharmaceutical company with an established product line in prostate cancer therapeutics and other areas of oncology.
Arsanis is a clinical - stage biopharmaceutical company developing targeted monoclonal antibodies for pre-emptive and post-infection treatment of serious infectious diseases.
Wragge Lawrence Graham & Co and McDermott Will & Emery have won instructions on a $ 1.3 bn (# 820m) collaboration deal between AstraZeneca and fellow biopharmaceutical company Innate Pharma.
One legal department is looking to the future with plans for a law firm scorecard and an objective means of evaluating outside counsel, according to a legal operations manager at a biopharmaceutical company.
Consistent with our responsibility as the world's leading biopharmaceutical company, we also collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world.
About Merck Animal Health For more than a century, Merck, a leading global biopharmaceutical company, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases.
ALAMEDA, Calif., May 20, 2009 (GLOBE NEWSWIRE)-- Avigen, Inc. (Nasdaq: AVGN) a biopharmaceutical company, announced today that it has been granted United States Patent No. 7,534,806, entitled «Method for Treating Neuropathic Pain and Associated Syndromes.»
VXGN is a biopharmaceutical company based in South San Francisco, California.
SAN DIEGO and ALAMEDA, Calif., June 25, 2009 (GLOBE NEWSWIRE)-- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq: MNOV — News) and the Hercules Market of the Osaka Securities Exchange (Code Number: 4875), and Avigen, Inc. (Nasdaq: AVGN — News), a biopharmaceutical company, today announced that they have confirmed their understanding of certain key terms for a proposed acquisition of Avigen by MediciNova that would combine the companies» broad neurological clinical development programs based on ibudilast (Avigen's AV - 411 and MediciNova's MN - 166).
PTC Therapeutics Inc., is a biopharmaceutical company focused on the discovery and development of orally administered, proprietary small - molecule drugs that target post-transcriptional control processes.
AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which is discovering, developing and commercializing targeted therapies to treat patients with cancer.
La Jolla Pharmaceutical Co. is a biopharmaceutical company engaged in the discovery, development and commercialization of therapeutics for chronic organ failure and cancer.
Adamis Pharmaceuticals Corp is is a biopharmaceutical company engaged in the development and commercialization of specialty pharmaceutical and biotechnology products in the therapeutic areas of respiratory disease, allergy, oncology and immunology.
Radius Health, Inc. a biopharmaceutical company, which engages in the discovery and development of therapeutics for the treatment of osteoporosis and other women's health conditions.
Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products.
Pulmatrix, Inc. (PULM) From The Konlin Letter Pulmatrix, Inc. (PULM) is a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary disease.
Sinovac Biotech Ltd. is biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including hepatitis A and B, seasonal influenza, H5N1 pandemic influenza and mumps, as well as animal rabies vaccine.
Sinovac Biotech, Ltd. is a fully integrated, profitable China - based biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases.
Nektar Therapeutics, Inc. is clinical - stage biopharmaceutical Company, which is engaged in the development of drug candidates that utilize its PEGylation & advanced polymer conjugate technology platforms.
Paraktek Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon its expertise in novel tetracycline chemistry.
This biopharmaceutical company rapidly rose in value from around $ 9.28 in December 2013 to $ 19.65 in January 2014.
AVGN (website here) is a «biopharmaceutical company engaged in developing and commercializing small molecule therapeutics to treat neurological and neuromuscular disorders.»
Press Release: Shire pays $ 825m to develop Renovo's scar - reduction remedy By Karen Attwood Thursday, 21 June 2007 Share Shire is to pay up to $ 825m (# 414m) to Renovo for the exclusive development and commercialisation rights to the biopharmaceutical company's groundbreaking scar - prevention drug.
On the one hand, the British - Dutch oil and gas giant Royal Dutch Shell ($ 220.05) and the US - American biopharmaceutical company Gilead Sciences ($ 15.21) paid out their quarterly dividend.
Bristol - Myers Squibb Company is a global biopharmaceutical Company, which is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceutical products on a global basis.
Chemocentryx, Inc. is a biopharmaceutical company engaged in discovering, developing and commercializing orally - administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer.
Acceleron Pharma, Inc. is a clinical stage biopharmaceutical company.
Today, the company is a premier research - intensive biopharmaceutical company.
Synergy Pharmaceuticals, Inc. is a development stage biopharmaceutical company, whose main focus is on the development of drugs to treat GI disorders and diseases.
Synergy Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of drugs to treat gastrointestinal disorders and diseases.
NewLink Genetics Corporation is a biopharmaceutical company focused on discovering, developing and commercializing novel immunotherapeutic products to improve cancer treatment options for patients and physicians.
Avigen, Inc. (NASDAQ: AVGN) has received an offer from MediciNova, Inc. (NASDAQ: MNOV), a biopharmaceutical company that is publicly traded on both the Nasdaq Global Market and the Hercules Market of the Osaka Securities Exchange (Code Number: 4875).
NTII is a biopharmaceutical company historically focused on developing treatments for central nervous system conditions and other serious unmet medical needs.
Avigen, Inc. (Nasdaq: AVGN), a biopharmaceutical company, today confirmed that BVF Acquisition LLC, a wholly owned subsidiary of Biotechnology Value Fund, L.P. (collectively, «BVF»), had commenced an unsolicited tender offer to purchase all of the outstanding shares of Avigen's common stock that BVF does not already own for $ 1.00 per share in cash.
Horizon Pharma Plc is a specialty biopharmaceutical company, which engages in the business of identifying, developing, acquiring and commercializing differentiated products that address unmet medical needs.
Endocyte, Inc. is a biopharmaceutical company, which develops targeted therapies for the treatment of cancer and inflammatory diseases.
Horizon Pharma, Inc is a biopharmaceutical company that is developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases.